HopeStage
Back to all studies
CompletedNCT06242535

GLY-LOW supplement study for postmenopausal women with obesity

About this titleRead the official source — NCT06242535
Interventional studyAges 56+United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 56 years.

Listed locations
GilletteSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 27, 2023
Recruitment status
Completed
Enrollment listed in the registry
13
Sponsor
Hoskinson Health and Wellness Clinic
Sponsor type
Hospital / academic medical center
Study type
Biological
Intervention type
Biological
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
Over 56 Years
Official registry ID
NCT06242535
Official title
Show the full official title

Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Gillette

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hoskinson Health and Wellness Clinic, a hospital or academic medical center.

Who was this study for?

Listed age limits: from 56 years.

Want to explore more studies?

Explore studies